Explore

ReutersReuters
France's Schneider Electric nears $20 billion deal to acquire US software group PTC, source says

France's Schneider Electric nears $20 billion deal to acquire US software group PTC, source says

By Sabrina Valle Oct 4 (Reuters) - France's Schneider Electric is nearing a deal to buy US software group PTC for about $20 billion, according to a person close to the deal on Sunday.
Rapid ReadRapid Read
Orano Med Expands Lead-212 Production with New U.S. Facility for Cancer Therapies

Orano Med Expands Lead-212 Production with New U.S. Facility for Cancer Therapies

Orano Med, a clinical-stage biotechnology company and subsidiary of the Orano group, is expanding its global manufacturing capabilities for lead-212-based targeted alpha therapies (TATs) for cancer treatment. Following the inauguration of its ATLab Valenciennes in France, which is Europe's first industrial-scale pharmaceutical facility dedicated to producing these radioligand therapies, Orano Med is also commissioning a similar production site in Indianapolis, in the U.S. This U.S. facility is designed to serve the North American market, mirroring the European site's goal of large-scale production to meet patient needs. The company's TATs utilize lead-212 (212Pb), an alpha-emitting radioisotope, as a potent therapeutic payload against cancer cells. Orano Med's strategy involves developing several 212Pb-based radioligand therapies combined with various targeting agents, with four drug candidates currently in clinical development and a broad preclinical pipeline. The logistical demands for these treatments a...
ReutersReuters
Schneider Electric to buy US software firm PTC in $22.6 billion deal

Schneider Electric to buy US software firm PTC in $22.6 billion deal

By Sabrina Valle Oct 5 (Reuters) - France's Schneider Electric struck its biggest deal ever on Monday, agreeing to buy PTC in an all-cash deal valuing the US software company's equity at around $22.6 billion, it said in a statement.
Rapid ReadRapid Read
FDA Launches Expedited IND Pilot Program and Updates Non-Animal Testing Regulations

FDA Launches Expedited IND Pilot Program and Updates Non-Animal Testing Regulations

The U.S. Food and Drug Administration (FDA) has initiated an Expedited Investigational New Drug (IND) Pilot program, now accepting applications. This program aims to accelerate the drug development process by pairing drug sponsors with Qualified Research Institutions (QRIs) to support IND application preparation. The pilot allows for a rolling review of individual IND components during the pre-IND phase, rather than requiring a complete package upfront, with the goal of reducing clinical holds and shortening the drug-to-first-dose timeline. Applications for this pilot are due by October 30, and the FDA anticipates selecting 8–10 sponsor–QRI pairs for the initial cohort. Concurrently, the FDA has issued a direct final rule replacing 'animal tests' with 'nonclinical tests' in its drug and biologics regulations, explicitly allowing non-animal methods like human cell cultures, organs-on-chips, and computer models for pre-human safety assessment. This change does not eliminate animal studies but clarifies that ...
TrendlineTrendline
SGS Offers Comprehensive Services for mRNA Therapeutics and Vaccines Development

SGS Offers Comprehensive Services for mRNA Therapeutics and Vaccines Development

SGS Offers Comprehensive Services for mRNA Therapeutics and Vaccines Development
Rochester Democrat and ChronicleRochester Democrat and Chronicle
Finger Lakes winery opens in 15th century barn shipped from France

Finger Lakes winery opens in 15th century barn shipped from France

A barn, built in France before Columbus made landfall, is now home to a new Finger Lakes winery.
TrendlineTrendline
Novartis Secures $7.8 Billion Licensing Deal with China's Abogen Biosciences for RNA Platform

Novartis Secures $7.8 Billion Licensing Deal with China's Abogen Biosciences for RNA Platform

Novartis Secures $7.8 Billion Licensing Deal with China's Abogen Biosciences for RNA Platform
VarietyVariety
New York’s Inaugural Muslim Film Festival Aims to Move Past Counter-Narratives, Unveils Lineup, Jury (EXCLUSIVE)

New York’s Inaugural Muslim Film Festival Aims to Move Past Counter-Narratives, Unveils Lineup, Jury (EXCLUSIVE)

A festival launching Oct. 11 at Manhattan’s SVA Theatre is positioning itself as an answer to the flattened, stereotyped picture of Muslims Western media often traffics in. The New York Muslim Film Festival (NYMFF), billed as the city’s first for Muslim filmmakers, wants them telling their own stories. Hassan Babar, the festival’s artistic director, said […]
ReutersReuters
Morning Bid: Yield to worst

Morning Bid: Yield to worst

By Anna Szymanski Oct 2 (Reuters) - The third quarter of 2026 won't be forgotten soon – even if bond investors might prefer to.
TrendlineTrendline
Sanofi Seeks Head of Platform Partnerships for Vaccine R in U.S. Locations

Sanofi Seeks Head of Platform Partnerships for Vaccine R in U.S. Locations

Sanofi Seeks Head of Platform Partnerships for Vaccine R in U.S. Locations
ReutersReuters
Take Five: Reality bites

Take Five: Reality bites

Oct 2 (Reuters) - Global markets are starting to wake up to the reality of borrowing costs at two-decade highs, oil above $100 a barrel and central bank rate hikes, which is heaping pressure on governments, investors and households and eroding some of the AI-driven enthusiasm in equities.
ReutersReuters
Tesla's car business back on growth path as deliveries beat forecasts

Tesla's car business back on growth path as deliveries beat forecasts

By Anhata Rooprai and Akash Sriram Oct 2 (Reuters) - Tesla is on course to end two straight years of falling sales after its third-quarter deliveries beat Wall Street estimates on Friday, with a rebound in Europe giving the automaker a way back to growth without US tax incentives.